<DOC>
	<DOC>NCT02301312</DOC>
	<brief_summary>This study evaluates the safety and performance of a new vascular graft made of POSS-PCU as a vascular access conduit for haemodialysis. 30 patients requiring access for dialysis will be enrolled and monitored at regular intervals for 18 months.</brief_summary>
	<brief_title>Clinical Study of POSS-PCU Vascular Grafts for Vascular Access</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Subjects requiring vascular access for haemodialysis Subjects with no suitable vein. Subjects aged 18 80 years old Subjects are able to give voluntary, written informed consent to participate in this clinical investigation and from whom consent has been obtained Patients of child bearing potential, who are sexually active, must agree to the use of 2 highly effective forms of contraception throughout their participation in the study and for 6 months after completion of treatment: Condom with spermicide. AND 1 of the following: Oral contraceptive or hormonal therapy (e.g. hormone implants). Placement of an intrauterine device. Subjects with predicted shortterm survival (less than 18 months) or poor prognosis (this will be on the discretion of the clinician in charge) Subjects with left ventricle ejection fraction (LVEF) &lt;20% diagnosed on ECHO either preprocedure or documented within the previous 3 months prior to consent. Pregnant or lactating Allergies to any constituents of the graft material Patients who are infected or colonized with Methicillin Resistant Staphylococcus Aureus (MRSA).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>